(Q38057979)

27 August 2017

title

MicroRNAs in cancer diagnosis and therapy: from bench to bedside (English)

1 reference

27 August 2017

1 reference

1 reference

Isamu Hoshino

1

1 reference

27 August 2017

Hisahiro Matsubara

series ordinal

2

1 reference

27 August 2017

publication date

6 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

43

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

467-478

1 reference

27 August 2017

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Connecting chromosomes, crisis, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetics: a historical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Cancer epigenetics: above and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetics and environmental chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

CpG islands and the regulation of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetic aberrations during oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Recent advances in histone deacetylase targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

DNA methylation in cancer development, diagnosis and therapy--multiple opportunities for genotoxic agents to act as methylome disruptors or remediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Active DNA demethylation: many roads lead to Rome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Loss of imprinting and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Linking the epigenetic 'language' of covalent histone modifications to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Histone modifications and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Chromatin-remodelling mechanisms in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Romidepsin: a novel histone deacetylase inhibitor for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-directed cleavage of HOXB8 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA regulation by RNA-binding proteins and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Expression profiling of microRNA using oligo DNA arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs: new players in cardiac injury and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA in central nervous system trauma and degenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Structure and activity of putative intronic miRNA promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Regulatory circuit of human microRNA biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

SNPs in human miRNA genes affect biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Principles of microRNA-target recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Specificity and functionality of microRNA inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Regulation of microRNA expression and function by nuclear receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-373 induces expression of genes with complementary promoter sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs and epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs, epigenetics and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Dysregulation of microRNAs in cancer: playing with fire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetic gene silencing in cancer: the DNA hypermethylome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA regulatory network in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Towards the human cancer epigenome: a first draft of histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetics: relations to disease and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Array comparative genomic hybridization and its applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

microRNAs and cancer: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

14-3-3ζ positive expression is associated with a poor prognosis in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

14-3-3ζ as a prognostic marker and therapeutic target for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

let-7 microRNA functions as a potential growth suppressor in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Effects of let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Let-7 microRNA inhibits the proliferation of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

The role of let-7 in cell differentiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA let-7: an emerging next-generation cancer therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

microRNAs join the p53 network--another piece in the tumour-suppression puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs and their target gene networks in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Frequent downregulation of miR-34 family in human ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MiR-34, SIRT1 and p53: the feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Beyond HPV: oncomirs as new players in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA expression profiles of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

miR-21: an oncomir on strike in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

PI(3)king apart PTEN's role in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA expression profiles in head and neck cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Lats2 is an essential mitotic regulator required for the coordination of cell division.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA regulation of DNA repair gene expression in hypoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Signatures of microRNAs and selected microRNA target genes in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA dysregulation in gastric cancer: a new player enters the game

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs as biomarkers of disease onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Exosomes/microvesicles as a mechanism of cell-to-cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Characterization of extracellular circulating microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Detection of cancer with serum miRNAs on an oligonucleotide microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs in body fluids--the mix of hormones and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNAs as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA sponges: progress and possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Shielding the messenger (RNA): microRNA-based anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA-like off-target transcript regulation by siRNAs is species specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Hidden reach of the micromanagers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Human cytomegalovirus US7 is regulated synergistically by two virally encoded microRNAs and by two distinct mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

MicroRNA delivery by cationic lipoplexes for lung cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Evaluation of online miRNA resources for biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-012-0392-5

Genome-wide hypomethylation in cancer may be a passive consequence of transformation

21 January 2018

1 reference

12 December 2020

Histone lysine methylation and demethylation pathways in cancer

1 reference

12 December 2020

Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas

1 reference

12 December 2020

Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers

1 reference

12 December 2020

Big roles of microRNAs in tumorigenesis and tumor development

1 reference

12 December 2020

Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer

1 reference

12 December 2020

Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes

1 reference

12 December 2020

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

1 reference

12 December 2020

DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer

1 reference

12 December 2020

Circulating microRNAs (miRNA) in serum of patients with prostate cancer

1 reference

12 December 2020

miR-21 microRNA expression in human gastric carcinomas and its clinical association

1 reference

12 December 2020

CpG island hypermethylation of tumor suppressor microRNAs in human cancer

1 reference

12 December 2020

Spi-1/PU.1: an oncogene of the Ets family

1 reference

12 December 2020

Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells

1 reference

12 December 2020

MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro.

1 reference

12 December 2020

10.1007/S00595-012-0392-5

Identifiers

DOI

1 reference

27 August 2017

1 reference